Healthgen Biotech specializes in molecular pharmaceutical research and development. Its commission is to use a state-of-art technology, rice endosperm cell specific expression platform (Oryzᴴⁱᴱˣᵖ), having high capacity to express proteins or small peptides in the rice grain, to develop the plant-made pharmaceuticals (PMP). The PMP provides a new approach for production of biopharmaceuticals.
Meanwhile, a series of recombinant proteins have also been developed as raw materials for cell culture,drug carriers, vaccine stabilizers, cell cryopreservation agents, and medical device embedding agents